How to Cite
Abstract
Type 2 diabetes mellitus is characterized as a chronic disease of a progressive nature, with a state of hyperglycemia and varying degrees of insulin deficiency and resistance. Education and support for diabetes self-control are critical to prevent acute complications and reduce the risk of long-term complications. Insulinization therapy has been an effective aid to improve the long-term control and quality of life of patients with type 2 diabetes mellitus. There are two large groups of insulins that are human insulins and insulin analogues. The former has determined to be an effective and less expensive option, for this reason doctors should be familiar with its use. They can use various schemes for insulin, the basal scheme is the one that has the greatest reduction in glycemic levels and lower risk of hypoglycemia. It is also simple which facilitates the adherence of patients to treatment.
Keywords
References
Mora G, Martín D, Moreno I, Jerez B, Puerto M, Cabral R. Insulinización temprana como una herramienta eficaz para mejorar el control metabólico del paciente diabético. ¿Cuándo? ¿Cómo? ¿Con qué?. Diabetes Práctica RedGDPS. 2017;8(Supl Extr 4): 1-24. https://doi.org/10.26322/2013.7923.1505400426.03
Lagunes R, Galindo I, Castillo A, Romero C, Rosas F. ¿Por qué los médicos no utilizan en forma temprana la insulinización en pacientes con diabetes mellitus tipo 2?: Un estudio cualitativo en una ciudad mexicana. Salud Colectiva. 2017;13(4):693. https://doi.org/10.18294/sc.2017.1341
Alemán J, Artola S, Ávila L, Barrot J, Barutell L, Benito B et al. Guía de diabetes tipo 2 para clínicos. Recomendaciones de la redGDPS [Internet]. 2018 [cited 8 February 2020];(1). Available from: https://www.redgdps.org/guia-de-diabetes-tipo-2-para-clinicos
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement 1):S14-S31. https://doi.org/10.2337/dc20-S002
Díaz Naya, L., & Delgado Álvarez, E. (2016). Diabetes mellitus. Criterios diagnósticos y clasificación. Epidemiología. Etiopatogenia. Evaluación inicial del paciente con diabetes. Medicine - Programa de Formación Médica Continuada Acreditado, 12(17), 935–946. https://doi.org/10.1016/j.med.2016.09.001
Wexler D. Insulin therapy in type 2 diabetes mellitus. UpToDate Inc [Internet]. 2019 [cited 3 March 2020];. Available from: https://www.uptodate.com/contents/insulin-therapy-in-type-2-diabetes-mellitus
Aguirre J, Hidalgo A, Mene M, Enguix D, Benayas A, Garcia M. Grado de control cardiovascular en pacientes diabéticos tipo 2 de acuerdo con objetivos individualizados: Estudio “CONCARDIA”. Sociedad Española de Médicos Generales y de Familia. 2018;7(4):140-145 http://dx.doi.org/10.24038/mgyf.2018.050
American Diabetes Association. Glycemic targets: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl. 1):S66–S76 https://doi.org/10.2337/dc20-S006
McCulloch D, Hayward R. Screening for type 2 diabetes mellitus. UpToDate Inc [Internet]. 2019 [cited 3 March 2020];. Available from: https://www.uptodate.com/contents/screening-for-type-2-diabetes-mellitus
Rodríguez-Lay E, Michahelles C. Análogos de insulina de acción prolongada versus insulina NPH en diabetes mellitus. Rev Soc Peru Med Interna. 2018;31(2):104-109.
Mata M. Tipos de insulina. Diabetes Práctica RedGDPS. 2017;8(Supl Extr 4):1-24. https://doi.org/10.26322/2013.7923.1505400426.03
INFAC. Actualzación de insulina. Boletín INFAC [Internet]. 2017 [cited 3 March 2020];25(3):22-30. Available from: https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/actualizacion-de-insulinas-44559
Lipska K, Parker M, Moffet H, Huang E, Karter A. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018;320(1):53. https://doi.org/10.1001/jama.2018.7993
Lipska K, Hirsch I, Riddle M. Human Insulin for Type 2 Diabetes. JAMA. 2017;318(1):23. https://doi.org/10.1001/jama.2017.6939
Machado J, Medina D, Echeverri L. Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins. Expert Opinion on Drug Safety. 2016;1(1):1-5. http://dx.doi.org/10.1080/14740338.2017.1273346
Girbés J, Escalada J, Mata M, Gomez F, Artola S, Fernández D et al. Consenso sobre tratamiento con insulina en la diabetes tipo 2. Endocrinología, Diabetes y Nutrición. 2018;65(1):1-8. https://doi.org/10.1016/j.endinu.2018.01.002
Gomez F, Escalada F, Menéndez E, Mata M, Ferrer J, Ezkurra P et al. Recomendaciones de la Sociedad Española de Diabetes (SED) para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: Actualización 2018. Endocrinología, Diabetes y Nutrición. 2018;65(10):611-624. https://doi.org/10.1016/j.endinu.2018.08.004
American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement 1):S98-S110. https://doi.org/10.2337/dc20-S009
McCulloch D. General principles of insulin therapy in diabetes mellitus. UpToDate Inc [Internet]. 2019 [cited 3 March 2020];. Available from: https://www.uptodate.com/contents/general-principles-of-insulin-therapy-in-diabetes-mellitus
Fuente G, Sinay I, Costa J, Puchulu F, Dieuzeide G, Rodriguez M et al. Insulinización en la diabetes mellitus tipo 2: Alternativas de intensificación. Medicina (Buenos Aires) [Internet]. 2016 [cited 29 February 2020];76(1):173 - 179. Available from: https://www.researchgate.net/publication/317532245_Insulinizacion_en_la_diabetes_mellitus_tipo_2_Alternativas_de_intensificacion
Chien M, Chen Y, Hung Y, Wang S, Lu W, Chen C et al. Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 2016;7(6):881-888. https://doi.org/10.1111/jdi.12532
Chacón F, Agobian G, Ramos M, Rangel L, Alvarado J, Adamek P et al. Eficacia del esquema de terapia de insulina basal/bolo vs basal/plus en pacientes diabéticos tipo 2. ResearchGate [Internet]. 2016 [cited 3 March 2020];32(1):2-7. Available from: https://www.researchgate.net/publication/314078004_EFICACIA_DEL_ESQUEMA_DE_TERAPIA_DE_INSULINA_BASALBOLO_VS_BASALPLUS_EN_PACIENTES_DIABETICOS_TIPO_2
Downie M, Kilov G, Wong J. Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens. Diabetes Therapy. 2016;7(4):641-657. https://doi.org/0.1007/s13300-016-0199-2
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2020 Array